THE LATEST
iCHOR news, press releases, and events
News & Press Releases
Real-World Limited Market Release Evidence iCHOR 14F iDVT Venous Reperfusion System
The iCHOR iDVT venous reperfusion system has demonstrated consistent safety, efficacy, and procedural performance across a diverse spectrum of clinical presentations in limited market release evaluation accessing patients in both Hospital and Ambulatory settings. Clinical…
iCHOR Funding Early Commercialization
iCHOR Vascular. Clearing the path As iCHOR Vascular finishes the limited market release (LMR) data and evaluation, we are transitioning into a planned early commercial funding round aimed at targeted revenue milestones combined with real-world…
The Silicon Review Names iCHOR Among Fastest Growing Companies of 2026
The Silicon Review has identified iCHOR Vascular as on of the fastest growing innovative companies on its radar to watch in 2026. The article summarizes iCHOR’s mission as follows: “Today, iCHOR Vascular is positioning itself…
iSWEEP in Action: New Clinical Case Studies from iCHOR
iCHOR has published a new set of clinical case studies spotlighting how physicians are putting iSWEEP to work across both hospital and out-patient settings. The collection currently features real-world experience from four sites: St Anthony’s…
The Six Pillars of No-Compromise Peripheral Thrombectomy
When it comes to peripheral thrombectomies, all too often, physicians are forced to choose between compromises such as: Effective clot removal or blood loss and/or vessel andvalve integrity Rapid intervention or the time spent in…
Explore iCHOR's New FAQ Sections
As an outgrowth of iCHOR’s evolution in leading the way on transformation of the peripheral thrombectomy sector, we are constantly being asked questions about both the big picture regarding market changes and specific details about…
Simplified Mechanical Thrombectomy Opens New Opportunities for ASCs and OBLs
Ambulatory Surgery Centers (ASCs) and Office-Based Labs (OBLs) are emerging as compelling alternatives to hospital-based care, offering patients better access at substantially lower cost. As site-of-care reimbursement evolves and technology matures, peripheral thrombectomy is now…
Understanding the Total Cost of Procedures for Thrombectomies
Hospitals routinely underestimate the true cost of thrombectomy because they focus on device price instead of the full episode of care. This article argues for a broader, “total cost” view that captures all direct and…
iCHOR Vascular, Simply Taking a Proven Surgical Fogarty Sweep into the Endovascular Labs
What inspired the creation of Ichor Vascular and the development of its core technology platform? The creation of Ichor Vascular was inspired by a clear clinical gap the founders observed while working with multiple thrombectomy…
About iCHOR
iCHOR was founded by Interventional Radiologist Dr. Troy Long and industry veteran Tim Blair. They identified an opportunity to develop new technologies to address these large unmet needs in treating peripheral vascular occlusions. This collaboration has lead to the development of the iSWEEP platform technology that has converted the tried and true Fogarty balloon sweep technique from an open surgery to a simple, minimally-invasive endovascular procedure.
Contact Us
Upcoming Events
The following are meetings and conferences that the iHCOR team will be attending. If you would like to meet with one of our team members, please email us at info@ichorvascular.com
